GSK plc (GSK) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: March 03, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

4.3B

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

GSK currently has 4.31B outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Mar 03, 2025	20-F filing \| 4314.3M shares outstanding	4.3B
Mar 05, 2024	20-F filing \| 4312.1M shares outstanding	4.3B
Mar 10, 2023	POS AM filing: GlaxoSmithKline may offer and sell up to an aggregate of $10,000,000,000 of debt securities from time to time in one or more series through this prospectus.	5.4B
Mar 10, 2023	20-F filing \| 4311.3M shares outstanding	4.3B
Mar 08, 2022	20-F filing \| 5387.0M shares outstanding	5.4B
Mar 12, 2021	20-F filing \| 5385.2M shares outstanding	5.4B

Back to GSK Details